Local cover image
Image from Google Jackets
Evaluation of pharmacotherapy of cancer pain in patients with head and neck cancer at a tertiary care teaching hospital
Publication details: New York SAGE 2024Edition: Vol.15(2), JuneDescription: 183-189pSubject(s): Online resources: In: Journal of pharmacology and pharmacotherapeuticsSummary: Head and Neck Cancers (HNC) account for 5% of all malignant tumours, but 80% of patients experience pain. As per the WHO analgesic ladder, analgesics are a cornerstone for the management of pain in HNC patients.| Item type | Current library | Status | Barcode | |
|---|---|---|---|---|
Articles Abstract Database
|
School of Pharmacy Archieval Section | Not for loan | 2025-0268 |
Total holds: 0
Head and Neck Cancers (HNC) account for 5% of all malignant tumours, but 80% of patients experience pain. As per the WHO analgesic ladder, analgesics are a cornerstone for the management of pain in HNC patients.
There are no comments on this title.
Log in to your account to post a comment.
Click on an image to view it in the image viewer